Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

New Zealand phase II trial for AVAC in pediatric atopic dermatitis

Nov. 19, 2003

Access files OraDisc A NDA

Nov. 19, 2003

EpiTan plans IND filing for Melanotan

Nov. 13, 2003

Clinical benefits of efalizumab in plaque-type psoriasis

Nov. 10, 2003

New HC-PTP inhibitors and their use as wound-healing agents claimed by Ontogen

Nov. 6, 2003

New cytochrome P-450RAI inhibitors and their use patented by Allergan

Nov. 4, 2003

Encouraging preliminary phase II results for LyphoDerm

Oct. 31, 2003

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

First North American trial of Adhibit

Oct. 30, 2003

Daivobet effective in severe psoriasis

Oct. 29, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....